UBS Group AG

Holdings History for CAPRICOR THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CAPR)

Symbol: CAPR on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$6,874,914	238,216	+113,499	+91%	$28.86	Q4 2025
30 Sep 2025	0%	-0%	$899,210	124,717	-424,710	-77%	$7.21	Q3 2025
30 Jun 2025	0%	+0%	$5,455,810	549,427	+156,084	+40%	$9.93	Q2 2025
31 Mar 2025	0%	+0%	$3,732,825	393,343	+270,525	+200%	$9.49	Q1 2025
31 Dec 2024	0%	+0%	$1,694,888	122,818	+109,700	+836%	$13.80	Q4 2024
30 Sep 2024	0%	+0%	$199,525	13,118	+4,431	+51%	$15.21	Q3 2024
30 Jun 2024	0%	+0%	$41,437	8,687	+7,187	+479%	$4.77	Q2 2024
31 Mar 2024	0%	+0%	$10,185	1,500	+1,500	NEW	$6.79	Q1 2024
30 Jun 2023		-0%	$0	0	-4,439	-100%	$24.50	Q2 2023
31 Mar 2023	0%	+0%	$18,733	4,439	+4,439	NEW	$4.22	Q1 2023
30 Sep 2022		-0%	$0	0	-29,352	-100%	$24.50	Q3 2022
30 Jun 2022	0%	+0%	$102,000	29,352	+22,562	+332%	$3.48	Q2 2022
31 Mar 2022	0%	+0%	$23,000	6,790	+3,042	+81%	$3.39	Q1 2022
31 Dec 2021	0%	+0%	$11,000	3,748	+3,748	NEW	$2.93	Q4 2021
30 Sep 2021		-0%	$0	0	-1,922	-100%	$24.50	Q3 2021
30 Jun 2021	0%	+0%	$10,000	1,922	+1,547	+413%	$5.20	Q2 2021
31 Mar 2021	0%	-0%	$2,000	375	-4,301	-92%	$5.33	Q1 2021
31 Dec 2020		0%	$1,000	400	0		$2.50 ^*	Q4 2020
31 Dec 2020	0%	+0%	$16,000	4,676	+2,776	+146%	$3.42	Q4 2020
30 Sep 2020	0%	+0%	$10,000	1,900	+900	+90%	$5.26	Q3 2020
30 Jun 2020	0%	-0%	$5,000	1,000	-439	-31%	$5.00	Q2 2020
31 Mar 2020	0%	-0%	$2,000	1,439	-3,974	-73%	$1.39	Q1 2020
31 Dec 2019	0%	+0%	$7,000	5,413	+5,159	+2031%	$1.29	Q4 2019
30 Sep 2019	0%	0%	$1,000	254	+254	NEW	$3.94	Q3 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.